The Michael J. Fox Foundation for Parkinson’s Research & AbbVie have partnered to create a multifaceted strategic health initiative, called Partners in Parkinson’s, which aims to fill in knowledge gaps, provide new educational tools and resources for the Parkinson’s community to help Parkinson’s patients and caregivers optimize care at every stage of the disease, now and in the future.

  • Partners in Parkinson’s hosts in-person educational events around the country that connect patients and caregivers with education and resources for managing Parkinson’s disease, as well as information on current Parkinson’s research and opportunities to meet other patients, caregivers and clinicians.
  • The Partners in Parkinson’s website connects patients with a first-of-its-kind movement disorder specialist finder provided in collaboration with the International Parkinson and Movement Disorder Society.
  • Parkinson’s Disease Advocates provide one-on-one support to patients and caregivers seeking advice and resources.

About The Michael J. Fox Foundation for Parkinson’s Research

The Michael J. Fox Foundation for Parkinson’s Research is dedicated to finding a cure for Parkinson’s disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson’s today. For further information on the foundation, please visit www.michaeljfox.org

About AbbVie

Abbvie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. For further information on the company, please visit www.abbvie.com